In the present study, we evaluated plasma levels of the prototypical acute phase protein CRP, Interleukin-1 receptor antagonist (IL-1Ra) which is synthesized and released by activated monocyte-macrophages at sites of tissue damageyinflammation and Interleukin-2 soluble receptor (sIL-2R), a specific marker of T-lymphocyte activation, in patients with mild ischaemic LVD.
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction / Abbate, A; Vecile, E; Fiotti, Nicola; Giansante, Carlo; Guarnieri, Gianfranco; DI SCIASCIO, G; Dobrina, Aldo. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 5:1(2003), pp. 23-25. [10.1016/S1388-9842(02)00117-4]
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction.
FIOTTI, NICOLA;GIANSANTE, CARLO;GUARNIERI, GIANFRANCO;DOBRINA, ALDO
2003-01-01
Abstract
In the present study, we evaluated plasma levels of the prototypical acute phase protein CRP, Interleukin-1 receptor antagonist (IL-1Ra) which is synthesized and released by activated monocyte-macrophages at sites of tissue damageyinflammation and Interleukin-2 soluble receptor (sIL-2R), a specific marker of T-lymphocyte activation, in patients with mild ischaemic LVD.| File | Dimensione | Formato | |
|---|---|---|---|
|
03 plasma.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Digital Rights Management non definito
Dimensione
198.41 kB
Formato
Adobe PDF
|
198.41 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
